Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the management of pancreatic cancer
Marco Del Chiaro, Toshitaka Sugawara, Sana D. Karam, et al.
BMJ (2023), pp. e073995-e073995
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Multiparametric MRI for Assessment of the Biological Invasiveness and Prognosis of Pancreatic Ductal Adenocarcinoma in the Era of Artificial Intelligence
Ben Y. Zhao, Buyue Cao, Tianyi Xia, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access | Times Cited: 1
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
Thomas F. Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
JAMA Oncology (2025)
Closed Access | Times Cited: 1
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Genetically predicted causal link between the plasma lipidome and pancreatic diseases: a bidirectional Mendelian randomization study
Liaoyi Lin, Yingbao Huang, Songzan Qian, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes
Zhiqin Wang, Jingyan Wei, Jingyi Sun, et al.
Nano Letters (2025)
Closed Access
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
Weidong Yu, Danyi Zhou, Fanhao Meng, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer
Jieru Li, Yiwei Dai, Tao Wang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 615-629
Closed Access
Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer
Minxue Chen, Xinyuan Zhou, Yong Fan, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis
Zehui Yao, Dailei Qin, Jianzhong Cao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The dual role of gut microbiota in pancreatic cancer: new insights into onset and treatment
Huijuan Cheng, Hongkai Guo, Chunling Wen, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC
Xing Liu, Yidan Shao, Yunjiang Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3379-3406
Open Access
Importance of increasing resection rates in pancreatic cancer treatment
Marco Del Chiaro, Hiroyuki Ishida, Richard D. Schulick
BJS Open (2025) Vol. 9, Iss. 2
Open Access
Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma
Hong-Sik Kim, Chang Gok Woo, Seung-Myoung Son, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 598-598
Open Access
Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer
Dan Wen, Qi Wang, Jin Ding, et al.
Molecular Pharmaceutics (2025)
Closed Access
Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study
Xu Yang, Yunmei Shi, Tao Jiang, et al.
European Journal of Radiology (2025), pp. 112070-112070
Closed Access
Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol
Elham Parichehreh, Ali Akbar Kiaei, Mahnaz Boush, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer
Pan Zhang, Haitao Shi, Ruochun Guo, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Closed Access | Times Cited: 1
Radiogenomic analysis for predicting lymph node metastasis and molecular annotation of radiomic features in pancreatic cancer
Yi Tang, Yi-xi Su, Jin-mei Zheng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective
Hanqiao Shao, Hongshu Fang, Yuan Li, et al.
Cost Effectiveness and Resource Allocation (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1558-1558
Open Access | Times Cited: 1
An Atypical Case of Pancreatic Cancer with Mesenchymal Differentiation in a Patient with Primary Lung Adenocarcinoma: Insights into Tumor Biology and Novel Therapeutic Pathways
Noura Abbas, Lama Zahreddine, Ayman Tawil, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2512-2512
Open Access | Times Cited: 1
Elevated Expression of Cell Adhesion, Metabolic, and Mucus Secretion Gene Clusters Associated with Tumorigenesis, Metastasis, and Poor Survival in Pancreatic Ductal Adenocarcinoma
Karthik Balakrishnan, Yi Xiao, Yuanhong Chen, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4049-4049
Open Access | Times Cited: 1
ASO Author Reflections: Is There a Role for Selective Adjuvant Radiotherapy in the Modern Era of Pancreatic Cancer Treatment?
Oskar Franklin, Sana D. Karam, Richard D. Schulick, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 7, pp. 4695-4696
Closed Access
Establishment of a prognostic model for pancreatic cancer based on mitochondrial metabolism related genes
Qinwen Ba, Xiong Wang, Yanjun Lu
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top